Cargando…

P1121: TAKEAIM LYMPHOMA- AN OPEN-LABEL, DOSE ESCALATION AND EXPANSION TRIAL OF EMAVUSERTIB (CA-4948) IN COMBINATION WITH IBRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES

Detalles Bibliográficos
Autores principales:	Joffe, E., Nowakowski, G., Tun, H., Rosenthal, A., Lunning, M., Ramchandren, R., Li, C.-C., Zhou, L., Martinez, E., von Roemeling, R., Earhart, R., McMahon, M., Isufi, I., Leslie, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430533/ http://dx.doi.org/10.1097/01.HS9.0000847352.16311.ea

Ejemplares similares

P1298: THE IRAK-4 INHIBITOR EMAVUSERTIB (CA-4948) FOR THE TREATMENT OF PRIMARY CNS LYMPHOMA
por: Von Roemeling, C., et al.
Publicado: (2022)

S129: TAKEAIM LEUKEMIA- A PHASE 1/2A STUDY OF THE IRAK4 INHIBITOR EMAVUSERTIB (CA-4948) AS MONOTHERAPY OR IN COMBINATION WITH AZACITIDINE OR VENETOCLAX IN RELAPSED/REFRACTORY AML OR MDS
por: Garcia-Manero, G., et al.
Publicado: (2022)

IRAK-4 inhibition: emavusertib for the treatment of lymphoid and myeloid malignancies
por: Parrondo, Ricardo D., et al.
Publicado: (2023)

Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK Inhibitors
por: Guidetti, Francesca, et al.
Publicado: (2023)

Oral IRAK-4 Inhibitor CA-4948 Is Blood-Brain Barrier Penetrant and Has Single-Agent Activity against CNS Lymphoma and Melanoma Brain Metastases
por: Von Roemeling, Christina A., et al.
Publicado: (2023)

1092. Increased Risk of Serious Infections in Mantle Cell Lymphoma Versus Other Hematologic Malignancies in Patients on Ibrutinib
por: Holowka, Thomas, et al.
Publicado: (2020)

1095. Investigation of Risk Factors Associated with Serious Bacterial, Viral and Invasive Fungal Infections in Hematologic Patients on Ibrutinib
por: Holowka, Thomas, et al.
Publicado: (2020)

1121. Implementation and Evaluation of a Virtual Microbiology Laboratory for Pharmacy Students
por: Gruenberg, Katherine, et al.
Publicado: (2020)

1121. Pediatric Urgent Care Providers’ Approach to Antibiotic Stewardship: A National Survey
por: Hamdy, Rana F, et al.
Publicado: (2019)

D11.2.1: DAΦNE IR design for the upgraded KLOE detector
por: Milardi, C
Publicado: (2011)

An Interstitial 20q11.21 Microdeletion Causing Mild Intellectual Disability and Facial Dysmorphisms
por: Iourov, Ivan Y., et al.
Publicado: (2013)

Cell Models for Chromosome 20q11.21 Amplification and Drug Sensitivities in Colorectal Cancer
por: Voutsadakis, Ioannis A.
Publicado: (2021)

Safety and activity of ibrutinib in combination with durvalumab in patients with relapsed or refractory follicular lymphoma or diffuse large B‐cell lymphoma
por: Herrera, Alex F., et al.
Publicado: (2019)

Breakpoint analysis of the recurrent constitutional t(8;22)(q24.13;q11.21) translocation
por: Mishra, Divya, et al.
Publicado: (2014)

Two patients with small chromosome 22q11.21 alterations and central nervous system abnormalities
por: Guy, Carrie, et al.
Publicado: (2015)

Pusa Basmati 1121 – a rice variety with exceptional kernel elongation and volume expansion after cooking
por: Singh, Vijaipal, et al.
Publicado: (2018)

Evaluation of loss of heterozygosity of chromosome 22q11.21 region in patients with congenital heart diseases
por: Behiry, Eman G., et al.
Publicado: (2018)

1121. Epidemiology and Risks for Infection Following Cytoreductive Surgery and Hyperthermic Intra-Peritoneal Chemotherapy at an Australian Centre
por: Smibert, Olivia, et al.
Publicado: (2018)

Functional in vivo and in vitro effects of 20q11.21 genetic aberrations on hPSC differentiation
por: Jo, Hye-Yeong, et al.
Publicado: (2020)

Mayer-Rokitansky-Küster-Hauser syndrome with 22q11.21 microduplication: a case report
por: Dell’Edera, Domenico, et al.
Publicado: (2021)

Ibrutinib-induced cardiomyopathy
por: Kyi, Htay Htay, et al.
Publicado: (2019)

Extrahepatic metabolism of ibrutinib
por: Rood, Johannes J. M., et al.
Publicado: (2020)

574. De-escalation of Broad Spectrum Antibiotics during Cytokine Release Syndrome with Haploidentical Hematopoietic Stem Cell Transplantation
por: Schiffer, Molly, et al.
Publicado: (2020)

Concurrent ibrutinib plus venetoclax in relapsed/refractory mantle cell lymphoma: the safety run-in of the phase 3 SYMPATICO study
por: Wang, Michael, et al.
Publicado: (2021)

Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis
por: Farshidfar, Farshad, et al.
Publicado: (2022)

A phase Ib, open label, dose escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia
por: Danilov, Alexey V., et al.
Publicado: (2021)

Ibrutinib: Rebound effect in the form of respiratory deterioration following the discontinuation of ibrutinib: case report
Publicado: (2021)

A High-Throughput Clinical Laboratory Methodology for the Therapeutic Monitoring of Ibrutinib and Dihydrodiol Ibrutinib
por: Karvaly, Gellért Balázs, et al.
Publicado: (2022)

Outcomes with ibrutinib by line of therapy and post‐ibrutinib discontinuation in patients with chronic lymphocytic leukemia: Phase 3 analysis
por: O'Brien, Susan M., et al.
Publicado: (2019)

Gain of 20q11.21 in Human Pluripotent Stem Cells Impairs TGF-β-Dependent Neuroectodermal Commitment
por: Markouli, C., et al.
Publicado: (2019)

Targets for Ibrutinib Beyond B Cell Malignancies
por: Berglöf, A., et al.
Publicado: (2015)

High-grade heart block associated with ibrutinib therapy
por: Vartanov, Alexander R., et al.
Publicado: (2021)

Ibrutinib for B cell malignancies
por: Novero, Aileen, et al.
Publicado: (2014)

Ibrutinib-Induced Skin Rash
por: Kirar, Sudhir, et al.
Publicado: (2021)

Ibrutinib: Pneumonitis: case report
Publicado: (2021)

Arrhythmia Patterns in Patients on Ibrutinib
por: Fazal, Muhammad, et al.
Publicado: (2022)

Final analysis of a phase 1/2b study of ibrutinib combined with carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma
por: Chari, Ajai, et al.
Publicado: (2020)

Ibrutinib as a treatment of hematologic autoimmune disorders in patients with indolent B‐cell lymphoma
por: Daniel, Adrien, et al.
Publicado: (2022)

Corrigendum: Nozaki T, Maruyama M (2022) Taxonomy of Homoeusa Kraatz, 1856 (Coleoptera, Staphylinidae) from the East Palearctic: I. Homoeusarufescens (Sharp, 1874) and a new allied species. ZooKeys 1121: 39–58. https://doi.org/10.3897/zookeys.1121.85489
por: Nozaki, Tsubasa, et al.
Publicado: (2022)

Author Correction: Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis
por: Farshidfar, Farshad, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_15vmn0e6a8mr8ritsvbpceupd5